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Background. Hyperleukocytosis is defined as a white blood cell (WBC) count in excess of 100,000 per mm3. Hyperleuko-
cytosis can cause leukostasis syndrome, the accumulation of leukemic blast cells within the capillary lumen, resulting in 
neurologic and pulmonary manifestations that can lead to intracranial haemorrhage and respiratory failure.
Objective. Identify a correct diagnostic approach, as the diagnosis of leukostasis in a patient suffering from acute leuke-
mia with hyperleukocytosis is made only clinically. A full blood cell count and a peripheral blood smear are essential for 
diagnosing leukostasis.
Case report. A 19 year old girl presented to the emergency department reporting onset of headache, absence of regression 
of symptoms after taking painkillers (non steroidal anti inflammatory drugs (NSAIDs)), intense fatigue and absence of fever. 
On examination, modest hypotension and anisocoria (with reactive pupils) were evidenced. A brain computed tomography 
(CT) scan was performed. Several, large areas of parenchymal haemorrhage were identified. A chest and abdomen CT scan 
was requested. The images demonstrated the presence of splenomegaly. The laboratory findings confirmed the suspected 
diagnosis, with a leukocyte count equal to 980,000 units per mm3 and a platelet count of 24,000 units per mm3.
Conclusion. Given the clinical case and its evolution, no report of recent onset of headache, especially in young patients, 
should be underestimated.
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Introduction
Hyperleukocytosis is defined as a white 
blood cell (WBC) count in excess of 
100,000 per mm3. Hyperleukocytosis 
can cause leukostasis syndrome, the 
accumulation of leukemic blast cells 
within the capillary lumen, resulting in 
neurologic and pulmonary manifes-
tations that can lead to intracranial 
haemorrhage and respiratory failure. 
The main objective of this article con-
sists of  identifying a correct diagnostic 
approach, as the diagnosis of leukosta-
sis in a patient suffering from acute leu-
kemia with hyperleukocytosis is made 
only clinically.
Case report
A 19 year old girl presented to the 
emergency department reporting onset 
of headache, absence of regression 
of symptoms after taking non steroi-
dal anti inflammatory drugs (NSAIDs), 
intense fatigue and absence of fever. 
On examination, modest hypoten-
sion, anisocoria (with reactive pupils), 
numerous ecchymosis on several parts 
of the body (legs and lower abdominal 
quadrants) and a slight deterioration of 
sensorium were evidenced. A brain CT 
was performed. Several, large areas of 
parenchymal haemorrhage (the largest 
being 11 mm in diameter) were identi-
fied (figure 1). A chest and abdomi-
nal computed tomography (CT) scan 
was requested. The images demon-
strated the presence of splenomegaly 
(diameter 15 to 22 cm) (figure 2) and 
numerous pathological lymph nodes 
(the largest of 2.8 cm) in the iliac, axil-
lary and aortic regions. These findings 
were   identified as indicative of acute 
leukemia by the radiologist. Given 
the mental deterioration of the patient 
(Glasgow coma scale [GCS] 10/11), 
an emergency blood transfusion was 
started (two units of blood and one unit 
of platelets). The laboratory confirmed 
the suspicion with a leukocyte count 
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equal to 980,000 units per mm3 and a 
platelet count of 24,000 units per mm3. 
The peripheral blood exam confirmed 
the presence of numerous lymphoid 
leukemic blasts in all microscopic fields 
(figure 3). The patient was first orally 




Hyperleukocytosis is defined as a WBC 
count in excess of 100,000 per mm3. (1) 
Hyperleukocytosis is a relevant prognostic 
factor in several types of leukaemias. (2) 
In acute leukaemia it carries a high early 
mortality rate. (3) Hyperleukocytosis can 
cause leukostasis syndrome, the accu-
mulation of leukemic cells within the capi-
llary lumen, resulting in neurological and 
pulmonary manifestations that can lead to 
intracranial haemorrhage and respiratory 
failure. (4) Hyperleukocytosis has been 
found to occur in 7.3% of paediatric pati-
ents with acute leukaemia. The conventio-
nal theory relates leukostasis to increased 
blood viscosity in microcirculation. More 
recent evidences suggest that adhesive 
interactions between leukemic blasts and 
endothelium result in endothelial damage. 
This is thought to be mediated by cytoki-
nes that trigger a chemotactic migration 
of blast cells. Adhesion molecules in leu-
kemic cells play a relevant role. Hyper-
leukocytosis can occur in patients with 
acute promyelocyte leukaemia treated 
with all-trans retinoic acid. It appears that 
the drug induces changes in adhesion 
receptors. The incidence of leukostasis is 
greater and occurs at a lower WBC count 
in acute myeloid leukaemia (AML) than 
in acute lymphoid leukaemia (ALL). (5) 
In ALL, intracerebral haemorrhage does 
not typically occur unless the WBC count 
exceeds 400,000 per mm3. (6) The visco-
sity of leukocytes is related to their fracti-
onal volume. Leukemic myeloblasts are 
roughly twice the size of leukemic lympho-
blasts; myeloid blasts are also less defor-
mable than lymphoid blasts and have a 
greater tendency to adhere to each other 
and to vascular endothelium, resulting in 
more capillary sludging. (7) Leukostasis 
incidence in leukaemia is as follows: AML, 
chronic myeloid leukaemia (CML), ALL 
and chronic lymphoid leukaemia (CLL). 
(7) Clinically evident leukostasis does not 
seem to occur during the chronic phase in 
CML and CLL, despite exceedingly high 
WBC counts. It can occur during blast 
crisis at much lower WBC counts. (8)
Patient presentation
Symptoms of leukostasis are related to 
vascular damage of involved parenchy-
Figure 1.  Brain computed tomography scan without contrast enhancement. 
Two large areas of intraparenchymal haemorrhage are evidenced.
Figure 2.  Abdomen computed tomography scan with arterial contrast enhance-
ment. Demonstration of splenomegaly.
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Figure 3.  Peripheral blood smear. Demonstration of lymphoid leukemic blasts.
mas. Hypoxemia and pulmonary infil-
trates are the most common pulmonary 
symptoms. Consequences of leukocyte 
infiltration into brain parenchyma may 
lead to altered mental status, headache 
and visual field defects. Onset of fever is 
common. Other reported manifestations 
include myocardial ischemia, renal vein 
thrombosis, bowel infarction and pria-
pism. Disseminated intravascular coag-
ulation (DIC) and thrombocytopenia can 
be found often. Automated laboratory 
tests may underestimate the degree of 
thrombocytopenia as leukocyte frag-
ments could be counted as platelets.
Diagnostic methods
Diagnosis of leukostasis is made clini-
cally. Main symptoms have been listed 
previously. The presence of pulmonary 
or cerebral symptoms should always 
suggest a blast crisis in patients with 
leukemia. A full blood cell count and a 
peripheral blood smear are essential for 
diagnosing leukostasis.
Treatment
Cytoreduction by leukapheresis is the 
most indicated therapy. The maintenance 
of a low value of blood viscosity is man-
datory. Heparin and NSAIDs should be 
avoided since they can aggravate clotting 
ability. If the platelet count is below 20,000 
to 25,000, a platelet transfusion should be 
set-up. (9) Kidney failure is a risk associa-
ted with blast crises. (9) The presence of 
more than one million leukocytes is asso-
ciated with a poor prognostic outcome. 
The infusion of crystalloids is indicated 
to maintain a low level of blood viscosity. 
It is mandatory after eliminating the risk 
of hemorrhage. Transfusion should be 
avoided in asymptomatic patients since 
it is possible to increase the risk of blee-
ding. (10)
Conclusion
Given the low incidence of hyperleuko-
cytosis and the possibility of confusing 
it with other acute conditions, it is nece-
ssary to emphasize the importance of 
a correct diagnostic procedure. Given 
the presenting symptoms and outcome 
of our patient, no case of headache 
should be underestimated. The blood 
count should be performed in all sus-
pected cases of leukostasis. This study 
emphasizes the importance of brain 
CT examination in patients with drug 
resistant migraine.
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